![]() |
市場調查報告書
商品編碼
1922811
日本生成式人工智慧市場規模、佔有率、趨勢及預測(按交付形式、技術類型、應用和地區分類,2026-2034年)Japan Generative AI Market Size, Share, Trends and Forecast by Offering Type, Technology Type, Application, and Region, 2026-2034 |
||||||
2025年,日本生成式人工智慧市場規模達10.146億美元。 IMARC Group預測,到2034年,該市場規模將達到40.495億美元,2026年至2034年的複合年成長率(CAGR)為16.63%。影像、影片和音訊生成技術的不斷進步,以及這些技術在醫療保健和媒體等行業的日益普及,加上自編碼器和生成對抗網路(GAN)等技術的融合,以及對人工智慧驅動的自動化和創造性解決方案日益成長的需求,都在顯著擴大日本生成式人工智慧的市場佔有率。
生成式人工智慧在醫學和藥物發現領域的崛起
日本醫療保健產業正迅速整合生成式人工智慧(AI),以加速藥物研發、醫學影像診斷和病患診斷。諸如生成對抗網路(GAN)和自編碼器等AI驅動模型正被用於生成合成醫學數據,從而助力疾病預測和治療方法最佳化。製藥公司正利用AI加速藥物研發並大幅降低研發成本。醫院和研究機構正利用AI提升醫學影像清晰度,幫助放射科醫師提升異常檢測的準確性,進而推動日本生成式AI市場的成長。日本對AI驅動的醫療創新的推動與政府強調智慧醫療解決方案的「社會5.0」計劃相契合。例如,Softbank Corporation集團、SB Intuitions公司和中外製藥株式會社於2025年1月30日簽署了一份合作備忘錄,共同探索在臨床開發過程中應用生成式AI。此次合作旨在開發專為製藥業設計的AI代理和大規模語言模型,以提高臨床試驗的效率和生產力。其最終目標是加速新藥研發,讓患者更快獲得最先進治療。法規結構也不斷完善,以確保AI在醫療保健領域的應用符合倫理標準。隨著日本推動AI主導的醫療保健轉型,對生成式AI解決方案的需求預計將會成長,這將進一步促進科技公司與醫療服務提供者之間的合作,從而改善患者預後並簡化醫學研究流程。
生成式人工智慧正在改變日本的媒體和娛樂產業
生成式人工智慧正在改變日本的媒體和娛樂產業,革新內容創作、動畫和數位藝術。人工智慧工具正被用於產生超逼真的視覺效果、簡化動畫製作流程、實現劇本自動化以及降低工作室的製作成本。動畫宣布,10家遊戲相關公司將在2025年3月19日至21日於舊金山舉行的遊戲開發者大會(GDC)日本館參展。展館將參展一個遊戲相關企業區,展示來自40多家日本開發商的70多款遊戲,以及包括中間件、人工智慧編輯器和獨立遊戲在內的各種展品。此外,JETRO在Steam平台推出的「GDC 2025-MADE IN JAPAN COLLECTION」收錄了來自40多家合作公司的遊戲。同時,人工智慧驅動的語音合成技術正在改變配音產業,實現逼真的配音和自動旁白。串流媒體平台也正在利用人工智慧技術進行個人化內容推薦,提升用戶參與度。隨著人工智慧生成的內容日趨複雜,原創性和版權保護等倫理問題正透過監管討論得到解決。生成式人工智慧的快速發展有望為日本娛樂產業開啟一個充滿創造力、效率和創新力的新時代,這對日本生成式人工智慧市場的前景有正面影響。
The Japan generative AI market size reached USD 1,014.6 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 4,049.5 Million by 2034, exhibiting a growth rate (CAGR) of 16.63% during 2026-2034. The ongoing advancements in image, video, and speech generation, increasing adoption across industries like healthcare and media, integration of technologies such as autoencoders and GANs, and rising demand for AI-driven automation and creative solutions are significantly expanding the Japan generative AI market share.
Rise of Generative AI in Healthcare and Drug Discovery
Japan's healthcare sector is rapidly integrating generative AI to accelerate drug discovery, medical imaging, and patient diagnostics. AI-driven models, such as Generative Adversarial Networks (GANs) and autoencoders, are being used to generate synthetic medical data, aiding in disease prediction and treatment optimization. Pharmaceutical companies are leveraging AI to reduce drug development timelines, potentially cutting research costs significantly. Hospitals and research institutions are utilizing AI for medical image enhancement, helping radiologists detect abnormalities with higher accuracy which is fueling Japan generative AI market growth. Japan's push for AI-driven healthcare innovation aligns with the government's Society 5.0 vision, emphasizing smart healthcare solutions. For instance, SoftBank Corp., SB Intuitions Corp., and Chugai Pharmaceutical Co., Ltd. announced a Memorandum of Understanding on January 30, 2025, to work together to investigate the use of generative AI in clinical development procedures. The goal of this partnership is to create AI agents and a big language model specifically for the pharmaceutical sector in order to increase clinical trial productivity and efficiency. The ultimate objective is to expedite the development of new drugs and provide patients with cutting-edge treatments more quickly. Regulatory frameworks are evolving to ensure AI applications in medicine maintain ethical standards. As Japan continues its AI-driven transformation in healthcare, the demand for generative AI solutions is expected to grow, fostering collaborations between tech firms and healthcare providers to enhance patient outcomes and streamline medical research.
To get more information on this market Request Sample
Generative AI Reshaping Japan's Media and Entertainment Industry
Generative AI is transforming Japan's media and entertainment landscape, revolutionizing content creation, animation, and digital art. AI-powered tools are being used to generate hyper-realistic visuals, streamline animation workflows, automate scriptwriting, and reducing production costs for studios. Japan's anime industry, known for its rich storytelling and intricate animation, is increasingly integrating AI to create high-quality character designs and backgrounds. Gaming companies are utilizing AI-generated assets to enhance realism and optimize game development processes. For instance, the Japan External Trade Organization (JETRO) declared on February 25, 2025, that ten Japanese game-related businesses would be hosted at the Japan Pavilion at the Game Developers Conference (GDC) 2025, which would take place in San Francisco from March 19 to 21. In addition to offering a demo area with more than 70 game titles from more than 40 Japanese developers, the pavilion will showcase a wide variety of items, such as middleware, AI editors, and independent games. Additionally, games from more than 40 collaborating firms are part of the "GDC 2025 - MADE IN JAPAN COLLECTION" that JETRO has offered on Steam. Additionally, AI-driven voice synthesis is reshaping the voice acting industry, allowing for realistic dubbing and automated narration. Streaming platforms are leveraging AI to personalize content recommendations and enhance user engagement. As AI-generated content becomes more sophisticated, ethical concerns surrounding originality and copyright protection are being addressed through regulatory discussions. With generative AI advancing rapidly, Japan's entertainment industry is poised for a new era of creativity, efficiency, and innovation, which is positively impacting the Japan generative AI market outlook.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.